Skip to main content

Advertisement

SpringerLink
Log in

Cellular and Molecular Biology

Comment on “The lingering mysteries of metastatic recurrence in breast cancer”

  • Comment
  • Published:
British Journal of Cancer Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Not applicable.

References

  1. Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer. 2021;124:13–26.

    Article  PubMed  Google Scholar 

  2. Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, et al. 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med. 2017;377:1836–46.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res. 2004;10:8152–62.

    Article  PubMed  Google Scholar 

  4. Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med. 2005;353:793–802.

    Article  CAS  PubMed  Google Scholar 

  5. Paget S. The distribition of secondary growths in cancer of the breast. Lancet. 1889;133:571–3.

    Article  Google Scholar 

  6. Jin X, Mu P. Targeting breast cancer metastasis. Breast Cancer. 2015;9:23–34.

    PubMed  PubMed Central  Google Scholar 

  7. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer incidence and mortality projections in the UK until 2035. Br J Cancer. 2016;115:1147–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hudson BI, Lippman ME. Targeting RAGE signaling in inflammatory disease. Annu Rev Med. 2018;69:349–64.

    Article  CAS  PubMed  Google Scholar 

  9. Kwak T, Drews-Elger K, Ergonul A, Miller PC, Braley A, Hwang GH, et al. Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis. Oncogene. 2017;36:1559–72.

    Article  CAS  PubMed  Google Scholar 

  10. Taub CJ, Lippman ME, Hudson BI, Blomberg BB, Diaz A, Fisher HM, et al. The effects of a randomized trial of brief forms of stress management on RAGE-associated S100A8/A9 in patients with breast cancer undergoing primary treatment. Cancer. 2019;125:1717–25.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lombardi Comprehensive Cancer Center and Department of Oncology, Georgetown University Medical Center, Washington, DC, USA

    Barry I. Hudson & Marc E. Lippman

Authors
  1. Barry I. Hudson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marc E. Lippman
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

BIH drafted and edited the manuscript. MEL drafted and edited the manuscript.

Corresponding author

Correspondence to Barry I. Hudson.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hudson, B.I., Lippman, M.E. Comment on “The lingering mysteries of metastatic recurrence in breast cancer”. Br J Cancer 128, 484–485 (2023). https://doi.org/10.1038/s41416-022-02012-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41416-022-02012-0

  • Springer Nature Limited

Search

Navigation